Abstract:Misfolding, aggregation, and aberrant accumulation of proteins are central components in the progression of neurodegenerative disease. Cellular molecular chaperone systems modulate proteostasis, and, therefore, are primed to influence aberrant protein-induced neurotoxicity and disease progression. Molecular chaperones have a wide range of functions from facilitating proper nascent folding and refolding to degradation or sequestration of misfolded substrates. In disease states, molecular chaperones can display protective or aberrant effects, including the promotion and stabilization of toxic protein aggregates. This seems to be dependent on the aggregating protein and discrete chaperone interaction. Small heat shock proteins (sHsps) are a class of molecular chaperones that typically associate early with misfolded proteins. These interactions hold proteins in a reversible state that helps facilitate refolding or degradation by other chaperones and co-factors. These sHsp interactions require dynamic oligomerization state changes in response to diverse cellular triggers and, unlike later steps in the chaperone cascade of events, are ATP-independent. Here, we review evidence for modulation of neurodegenerative disease-relevant protein aggregation by sHsps. This includes data supporting direct physical interactions and potential roles of sHsps in the stewardship of pathological protein aggregates in brain. A greater understanding of the mechanisms of sHsp chaperone activity may help in the development of novel therapeutic strategies to modulate the aggregation of pathological, amyloidogenic proteins. sHsps-targeting strategies including modulators of expression or post-translational modification of endogenous sHsps, small molecules targeted to sHsp domains, and delivery of engineered molecular chaperones, are also discussed.

Could Small Heat Shock Protein HSP27 Be a First-Line Target for Preventing Protein Aggregation in Parkinson’s Disease?

Exploring Heat Shock Proteins As Therapeutic Targets for Parkinson’s Disease

Preventing α-synuclein aggregation: The role of the small heat-shock molecular chaperone proteins

Heat Shock Protein 90 in Parkinson's Disease: Profile of a Serial Killer

Linking Heat Shock Protein 70 and Parkin in Parkinson’s Disease

Linking Heat Shock Protein 70 and Parkin in Parkinson's Disease.

Heat Shock Protein 90 in Neurodegenerative Diseases

Molecular chaperones and Parkinson's disease

HSP27: Mechanisms of Cellular Protection Against Neuronal Injury.

Physiological and Pathological Functions of Neuronal Hemoglobin: A Key Underappreciated Protein in Parkinson’s Disease

Small Heat Shock Proteins, Big Impact on Protein Aggregation in Neurodegenerative Disease

HSPB6: A lipid-dependent molecular chaperone inhibits α-synuclein aggregation

Heat shock protein 70 suppresses neuroinflammation induced by α-synuclein in astrocytes

The small heat shock protein B8 (HSPB8) efficiently removes aggregating species of dipeptides produced in C9ORF72-related neurodegenerative diseases

Molecular Chaperones and Co-Chaperones in Parkinson Disease

Molecular Chaperones, Alpha-Synuclein, and Neurodegeneration

Molecular chaperones and protein folding as therapeutic targets in Parkinson’s disease and other synucleinopathies

The Effect of Oxidized Dopamine on the Structure and Molecular Chaperone Function of the Small Heat-Shock Proteins, αB-Crystallin and Hsp27

Different anti-aggregation and pro-degradative functions of the members of the mammalian sHSP family in neurological disorders

Mechanistic insights into heat shock protein 27, a potential therapeutic target for cardiovascular diseases

Heat Shock Proteins Reduce Alpha-Synuclein Aggregation Induced by Mpp+ in Sk-N-Sh Cells